Physician profile

Todd W Stuckey

Family Medicine · York, NE

NPI 1154377810

$4,583.92

in general payments reported to CMS, 2019-2025

41 companies · $338 in 2025

The $338 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,143.71

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,234.20 2019-2025 Qulipta, Vraylar, Teflaro
Novo Nordisk INC $438.38 2019-2025 Ozempic, Rybelsus, Wegovy
Amgen INC. $411.45 2019-2025 Otezla, Repatha, Evenity
Allergan, INC. $351.17 2019-2020
Astellas Pharma US INC $211.17 2019-2025 Veozah
Astrazeneca Pharmaceuticals LP $201.27 2021-2025 Airsupra, Farxiga, Breztri
Janssen Pharmaceuticals, INC $198.05 2020-2024 Xarelto
Aimmune Therapeutics, INC. $160.86 2024
Exact Sciences Corporation $146.65 2023-2024 Cologuard Collection Kit
Philips North America LLC $110.56 2019-2023
Bayer Healthcare Pharmaceuticals INC. $106.30 2021-2025
Pfizer INC. $88.81 2019-2024
Merck Sharp & Dohme LLC $73.22 2023-2024 Gardasil 9, Vaxneuvance, Capvaxive
Itamar Medical INC $54.34 2022
Boehringer Ingelheim Pharmaceuticals, INC. $53.35 2019-2022
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Lilly USA, LLC $51.88 2022-2023 Trulicity, Mounjaro
Xeris Pharmaceuticals, INC. $49.32 2023 Gvoke Hypopen
Dexcom, INC. $45.56 2025 Dexcom G6 Transmitter
Novartis Pharmaceuticals Corporation $45.32 2019-2023
Genentech USA, INC. $43.62 2019-2022
Sanofi-Aventis U.S. LLC $43.25 2019-2021
Biogen, INC. $36.46 2021-2024
Glaxosmithkline, LLC. $36.28 2020-2023 Bexsero, Shingrix
Eisai INC. $35.10 2020-2021
Otsuka America Pharmaceutical, INC. $32.24 2025 Rexulti
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $30.82 2023-2025 Xifaxan
Medtronic, INC. $28.44 2022
Ultragenyx Pharmaceutical INC. $28.43 2021-2022
Mylan Specialty L.P. $27.22 2020-2021
Daiichi Sankyo INC. $26.41 2020-2021
Organon LLC $25.71 2022
E.R. Squibb & Sons, L.L.C. $18.86 2025 Eliquis
Boston Scientific Corporation $18.58 2023 Watchman Access System
Sanofi Pasteur INC. $17.95 2023
Lundbeck LLC $17.89 2025 Rexulti
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $15.61 2025 Caplyta
Lexicon Pharmaceuticals, INC. $15.10 2024
Portola Pharmaceuticals, LLC $14.68 2019
Esperion Therapeutics, INC. $14.21 2025 Nexletol
Idorsia Pharmaceuticals US INC $13.27 2022
Kowa Pharmaceuticals America, INC. $11.93 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Todd W Stuckey

$4,583.92

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $338 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/51598/todd-w-stuckey

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.